| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.82B | $4.70B | $4.52B |
| YoY Revenue Growth % | +2.7% | +3.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.11B | $2.44B | $2.54B |
| Operating Margin % | 43.6% | 52.1% | 56.1% |
| Net Income (GAAP) | $1.78B | $2.07B | $2.15B |
| EBITDA (Normalized) | $2.28B | $2.61B | $2.70B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.19B | $3.13B | $3.25B |
| Capital Expenditures (CapEx) | $217.1M | $211.3M | $203.3M |
| Free Cash Flow (FCF) | $2.97B | $2.92B | $3.04B |
| FCF Margin % | 61.6% | 62.1% | 67.4% |
| Return on Invested Capital (ROIC %) | 12.0% | 14.1% | 10.2% |
| Cash & Short-Term Equivalents | $318.1M | $447.4M | — |
| Total Debt (Short + Long Term) | $4.89B | $4.47B | $7.62B |
| Total Stockholders' Equity | $9.25B | $9.71B | $15.64B |